102 related articles for article (PubMed ID: 11600616)
1. Correction: Meningeal carcinomatosis from breast carcinoma responsive to trastuzumab.
Pestalozzi BC
J Clin Oncol; 2001 Oct; 19(20):4091. PubMed ID: 11600616
[No Abstract] [Full Text] [Related]
2. Meningeal carcinomatosis from breast carcinoma responsive to trastuzumab.
Baculi RH; Suki S; Nisbett J; Leeds N; Groves M
J Clin Oncol; 2001 Jul; 19(13):3297-8. PubMed ID: 11432901
[No Abstract] [Full Text] [Related]
3. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report.
Stemmler HJ; Mengele K; Schmitt M; Harbeck N; Laessig D; Herrmann KA; Schaffer P; Heinemann V
Anticancer Drugs; 2008 Sep; 19(8):832-6. PubMed ID: 18690096
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.
Bendell JC; Domchek SM; Burstein HJ; Harris L; Younger J; Kuter I; Bunnell C; Rue M; Gelman R; Winer E
Cancer; 2003 Jun; 97(12):2972-7. PubMed ID: 12784331
[TBL] [Abstract][Full Text] [Related]
5. Use of intrathecal trastuzumab in a patient with carcinomatous meningitis.
Laufman LR; Forsthoefel KF
Clin Breast Cancer; 2001 Oct; 2(3):235. PubMed ID: 11899418
[No Abstract] [Full Text] [Related]
6. Trastuzumab for breast cancer-related carcinomatous meningitis.
Robins HI; Liu G; Hayes L; Mehta M
Clin Breast Cancer; 2002 Jan; 2(4):316. PubMed ID: 11899365
[No Abstract] [Full Text] [Related]
7. Meningeal carcinomatosis from breast cancer treated with intrathecal trastuzumab.
Platini C; Long J; Walter S
Lancet Oncol; 2006 Sep; 7(9):778-80. PubMed ID: 16945774
[No Abstract] [Full Text] [Related]
8. [Trastuzumab in metastatic breast carcinoma].
Susnjar S; Bosnjak S; Radulovic S
Srp Arh Celok Lek; 2001; 129(5-6):147-52. PubMed ID: 11797464
[No Abstract] [Full Text] [Related]
9. Meningeal carcinomatosis in HER2-overexpressing breast cancers.
Bidard FC; Guilhaume MN; Gauthier H; Cottu PH; Diéras V; Pierga JY
J Neurooncol; 2009 Jun; 93(2):287-8. PubMed ID: 19139826
[No Abstract] [Full Text] [Related]
10. [Trastuzumab and blood-brain barrier].
Platini C
Bull Cancer; 2007 Oct; 94(10):857-9. PubMed ID: 17964978
[TBL] [Abstract][Full Text] [Related]
11. [A case of advanced breast cancer with meningeal carcinomas and orbital metastasis successfully treated with multi-disciplinary therapy].
Sakurai K; Amano S; Enomoto K; Matsuo S
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1913-5. PubMed ID: 17212145
[TBL] [Abstract][Full Text] [Related]
12. High-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer.
Mir O; Ropert S; Alexandre J; Lemare F; Goldwasser F
Ann Oncol; 2008 Nov; 19(11):1978-80. PubMed ID: 18845838
[No Abstract] [Full Text] [Related]
13. Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier.
Stemmler HJ; Schmitt M; Willems A; Bernhard H; Harbeck N; Heinemann V
Anticancer Drugs; 2007 Jan; 18(1):23-8. PubMed ID: 17159499
[TBL] [Abstract][Full Text] [Related]
14. [Early detection of leptomeningeal metastasis in patients with metastatic breast carcinoma: validation of CA 15-3 measurement in cerebrospinal fluid].
Gauchez AS; Pez E; Boutonnat J; Bourre JC; Pelletier L; Payan R; Mousseau M
Ann Biol Clin (Paris); 2007; 65(6):653-8. PubMed ID: 18039611
[TBL] [Abstract][Full Text] [Related]
15. Images in clinical medicine. Meningeal carcinomatosis in breast cancer.
Ornstein DL; Frederickson K
N Engl J Med; 2000 Apr; 342(15):1093. PubMed ID: 10760309
[No Abstract] [Full Text] [Related]
16. Intrathecal trastuzumab: dose matters.
Hofer S; Mengele K; Stemmler HJ; Schmitt M; Pestalozzi B
Acta Oncol; 2012 Sep; 51(7):955-6. PubMed ID: 22524214
[No Abstract] [Full Text] [Related]
17. Pleomorphic lobular carcinoma of the breast: four long-term responders to trastuzumab--coincidence or hint?
Mahtani RL; Vogel CL
J Clin Oncol; 2008 Dec; 26(35):5823-4. PubMed ID: 19001341
[No Abstract] [Full Text] [Related]
18. [High cost of trastuzumab for the treatment of mammary carcinoma in The Netherlands].
Offerhaus L
Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1426-7; author reply 1427. PubMed ID: 16841595
[No Abstract] [Full Text] [Related]
19. Survival after brain metastases from breast cancer in the trastuzumab era.
Kirsch DG; Ledezma CJ; Mathews CS; Bhan AK; Ancukiewicz M; Hochberg FH; Loeffler JS
J Clin Oncol; 2005 Mar; 23(9):2114-6; author reply 2116-7. PubMed ID: 15774813
[No Abstract] [Full Text] [Related]
20. Brain metastases in patients receiving trastuzumab for breast cancer.
Salmaggi A; Silvani A; Boiardi A
Neurol Sci; 2007 Mar; 28(1):1. PubMed ID: 17385088
[No Abstract] [Full Text] [Related]
[Next] [New Search]
